Breast cancer is classified into three major clinical subtypes depending on the expression of the hormone receptors (HR) – estrogen receptor (ER) and progesterone receptor (PR) – and the human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and breast carcinoma.